Literature DB >> 35698175

Correction: Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217.

Colin Groot1, Claudia Cicognola2, Divya Bali2, Gallen Triana-Baltzer3, Jeffrey L Dage4, Michael J Pontecorvo5,6, Hartmuth C Kolb3, Rik Ossenkoppele2,7, Shorena Janelidze2, Oskar Hansson8.   

Abstract

Entities:  

Year:  2022        PMID: 35698175      PMCID: PMC9190141          DOI: 10.1186/s13195-022-01023-6

Source DB:  PubMed          Journal:  Alzheimers Res Ther            Impact factor:   8.823


× No keyword cloud information.
Correction: Alzheimers Res Ther 14, 67 (2022) https://doi.org/10.1186/s13195-022-01005-8 Following the publication of the original article [1] the authors reported that spelling of Dr. Rik Ossenkoppele’s last name was accidentally misspelled as “Osssenkoppele (with three s's)” rather than “Ossenkoppele”. The original article [1] has been updated.
  1 in total

1.  Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217.

Authors:  Colin Groot; Claudia Cicognola; Divya Bali; Gallen Triana-Baltzer; Jeffrey L Dage; Michael J Pontecorvo; Hartmuth C Kolb; Rik Ossenkoppele; Shorena Janelidze; Oskar Hansson
Journal:  Alzheimers Res Ther       Date:  2022-05-14       Impact factor: 8.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.